IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.100
-0.010 (-0.90%)
Feb 21, 2025, 4:00 PM EST - Market closed
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $72.47 million as of February 21, 2025. Its market cap has decreased by -38.89% in one year.
Market Cap
72.47M
Enterprise Value
-5.70M
1-Year Change
-38.89%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $72.47M, a decrease of -80.38%. That is a compound annual growth rate of -38.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 72.47M | 19.57% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |